The COX-1 relevance in ovarian cancer is also indirectly witnessed by the major efficacy of aspirin, a stronger COX-1 than COX-2 inhibitor, in COX-1-overexpressing in vitro and in vivo models of ovarian cancer [119,120,121,122]. This evidence concerns the gene PTGS1 and ovarian carcinoma.